Analysis: HIV generics under threat from tighter patenting rules
Reading time: (Number of words: )
VIENNA Monday, August 02, 2010 (IRIN) - Most of the estimated 5.2 million people worldwide on antiretroviral (ARV) treatment are taking generic versions manufactured primarily in India, but tighter global intellectual property rights and trade rules could shut down "the pharmacy of the developing world".
View online : http://www.irinnews.org/report...
Poems for the Hazara
The Anthology of 125 Internationally Recognized Poets From 68 Countries Dedicated to the Hazara
Order Now
